Biomedical and Biotechnology,
A. Rafie Lak; O. Vahidi
Volume 15, Issue 3 , September 2018, , Pages 34-52
Abstract
This paper presents using the fractional PImDn controller module which manipulates insulin infusion rate to maintain normoglycemia in subjects with type 1 diabetes. To prevent severe hypoglycemia, a conventional proportional controller is used to regulate glucagon infusion rate when the blood glucose ...
Read More
This paper presents using the fractional PImDn controller module which manipulates insulin infusion rate to maintain normoglycemia in subjects with type 1 diabetes. To prevent severe hypoglycemia, a conventional proportional controller is used to regulate glucagon infusion rate when the blood glucose levels fall below a threshold. Two sets of controller parameters are obtained and evaluated. For the first tuning set, clinical data from an oral glucose tolerance test taken from a group of healthy subjects are used to obtain the controller parameters such that it can mimic a real healthy pancreas. To obtain the second tuning set, the controller parameters are optimized through a sequential quadratic programming algorithm. Using the second tuning set, the in silico 2-hour postprandial test result and comparing it with the glucose concentration trajectory of the healthy subjects show that the controller performs well in returning the blood sugar levels into the glucose homeostasis while keeping the plasma insulin concentration within the acceptable physiological range. It is indicated that the manipulation of glucagon infusion rate is effective in hypoglycemia prevention if more aggressive controller settings are chosen or dysfunctional insulin infusion occurs.
Biomedical and Biotechnology,
Arezou Soroushnia; Fariba Ganji; Seyed Mojtaba Taghizadeh
Volume 13, Issue 4 , November 2016, , Pages 1-13
Abstract
Desmopressin acetate is a potent synthetic peptide hormone. A more acceptable route of Desmopressin acetate is a potent synthetic peptide hormone. That is administered via parenteral, intranasal, and oral routes. A more acceptable route of administration with potentially good bioavailability could be ...
Read More
Desmopressin acetate is a potent synthetic peptide hormone. A more acceptable route of Desmopressin acetate is a potent synthetic peptide hormone. That is administered via parenteral, intranasal, and oral routes. A more acceptable route of administration with potentially good bioavailability could be offered by transdermal delivery. The present work reports on the development of water-in-oil (w/o) microemulsions for the transdermal administration of desmopressin acetate. A water-in-oil nano/submicron emulsions for transdermal administration of desmopressin developed. Its skin penetration profiles determined using Franz-diffusion cell. Pseudo-ternary phase diagrams for emulsion regions constructed. Effects of hydrophilic-lipophilic balance (HLB), ratio of surfactants and co-surfactant mixture to oil phase (Smix/oil), and ratio of surfactants to co-surfactant (S/Cs) on skin flux evaluated. Skin flux was increased when S/Cs and Smix/oil were decreased, and HLB was increased. Optimized formulation was obtained as: HLB=8, S/Cs=3 and Smix/oil=5.4, with average particle size of 69nm. The optimized nano/submicron emulsions increased desmopressin skin flux 4.45 fold relative to drug solution.